232 related articles for article (PubMed ID: 11275363)
1. Taxol-induced cell cycle arrest and apoptosis: dose-response relationship in lung cancer cells of different wild-type p53 status and under isogenic condition.
Das GC; Holiday D; Gallardo R; Haas C
Cancer Lett; 2001 Apr; 165(2):147-53. PubMed ID: 11275363
[TBL] [Abstract][Full Text] [Related]
2. Taxol-induced mitotic block triggers rapid onset of a p53-independent apoptotic pathway.
Woods CM; Zhu J; McQueney PA; Bollag D; Lazarides E
Mol Med; 1995 Jul; 1(5):506-26. PubMed ID: 8529117
[TBL] [Abstract][Full Text] [Related]
3. Taxol-induced apoptosis depends on MAP kinase pathways (ERK and p38) and is independent of p53.
Bacus SS; Gudkov AV; Lowe M; Lyass L; Yung Y; Komarov AP; Keyomarsi K; Yarden Y; Seger R
Oncogene; 2001 Jan; 20(2):147-55. PubMed ID: 11313944
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of Taxol-induced cell death are concentration dependent.
Torres K; Horwitz SB
Cancer Res; 1998 Aug; 58(16):3620-6. PubMed ID: 9721870
[TBL] [Abstract][Full Text] [Related]
5. Taxol-mediated augmentation of CD95 ligand-induced apoptosis of human malignant glioma cells: association with bcl-2 phosphorylation but neither activation of p53 nor G2/M cell cycle arrest.
Roth W; Wagenknecht B; Grimmel C; Dichgans J; Weller M
Br J Cancer; 1998; 77(3):404-11. PubMed ID: 9472635
[TBL] [Abstract][Full Text] [Related]
6. Apoptosis as a measure of chemosensitivity to cisplatin and taxol therapy in ovarian cancer cell lines.
Gibb RK; Taylor DD; Wan T; O'Connor DM; Doering DL; Gerçel-Taylor C
Gynecol Oncol; 1997 Apr; 65(1):13-22. PubMed ID: 9103385
[TBL] [Abstract][Full Text] [Related]
7. Paclitaxel sensitivity correlates with p53 status and DNA fragmentation, but not G2/M accumulation.
Rakovitch E; Mellado W; Hall EJ; Pandita TK; Sawant S; Geard CR
Int J Radiat Oncol Biol Phys; 1999 Jul; 44(5):1119-24. PubMed ID: 10421546
[TBL] [Abstract][Full Text] [Related]
8. Disruption of p53 function in immortalized human cells does not affect survival or apoptosis after taxol or vincristine treatment.
Fan S; Cherney B; Reinhold W; Rucker K; O'Connor PM
Clin Cancer Res; 1998 Apr; 4(4):1047-54. PubMed ID: 9563901
[TBL] [Abstract][Full Text] [Related]
9. Loss of normal p53 function confers sensitization to Taxol by increasing G2/M arrest and apoptosis.
Wahl AF; Donaldson KL; Fairchild C; Lee FY; Foster SA; Demers GW; Galloway DA
Nat Med; 1996 Jan; 2(1):72-9. PubMed ID: 8564846
[TBL] [Abstract][Full Text] [Related]
10. Molecular effects of taxol and caffeine on pancreatic cancer cells.
Gururajanna B; Al-Katib AA; Li YW; Aranha O; Vaitkevicius VK; Sarkar FH
Int J Mol Med; 1999 Nov; 4(5):501-7. PubMed ID: 10534572
[TBL] [Abstract][Full Text] [Related]
11. Induction of apoptosis and cell cycle-specific change in expression of p53 in normal lymphocytes and MOLT-4 leukemic cells by nitrogen mustard.
Bhatia U; Danishefsky K; Traganos F; Darzynkiewicz Z
Clin Cancer Res; 1995 Aug; 1(8):873-80. PubMed ID: 9816057
[TBL] [Abstract][Full Text] [Related]
12. Radiosensitization in sarcoma cell lines with a p53 missense mutation correlates with prevention of irradiation G2/M arrest but not with induction of apoptosis.
Bache M; Oehlmann S; Meye A; Bartel F; Kappler M; Würl P; Schmidt H; Rath FW; Dunst J; Taubert H
Oncol Rep; 2001; 8(5):1007-11. PubMed ID: 11496306
[TBL] [Abstract][Full Text] [Related]
13. Taxol-induced growth arrest and apoptosis is associated with the upregulation of the Cdk inhibitor, p21WAF1/CIP1, in human breast cancer cells.
Choi YH; Yoo YH
Oncol Rep; 2012 Dec; 28(6):2163-9. PubMed ID: 23023313
[TBL] [Abstract][Full Text] [Related]
14. Schedule-dependent cytotoxicity of SN-38 in p53 wild-type and mutant colon adenocarcinoma cell lines.
te Poele RH; Joel SP
Br J Cancer; 1999 Dec; 81(8):1285-93. PubMed ID: 10604724
[TBL] [Abstract][Full Text] [Related]
15. BZML, a novel colchicine binding site inhibitor, overcomes multidrug resistance in A549/Taxol cells by inhibiting P-gp function and inducing mitotic catastrophe.
Bai Z; Gao M; Zhang H; Guan Q; Xu J; Li Y; Qi H; Li Z; Zuo D; Zhang W; Wu Y
Cancer Lett; 2017 Aug; 402():81-92. PubMed ID: 28576750
[TBL] [Abstract][Full Text] [Related]
16. Low concentrations of paclitaxel induce cell type-dependent p53, p21 and G1/G2 arrest instead of mitotic arrest: molecular determinants of paclitaxel-induced cytotoxicity.
Giannakakou P; Robey R; Fojo T; Blagosklonny MV
Oncogene; 2001 Jun; 20(29):3806-13. PubMed ID: 11439344
[TBL] [Abstract][Full Text] [Related]
17. Failure of taxol-based combination chemotherapy for malignant glioma cannot be overcome by G2/M checkpoint abrogators or altering the p53 status.
Borbé R; Rieger J; Weller M
Cancer Chemother Pharmacol; 1999; 44(3):217-27. PubMed ID: 10453723
[TBL] [Abstract][Full Text] [Related]
18. The bioreductive agent RH1 and gamma-irradiation both cause G2/M cell cycle phase arrest and polyploidy in a p53-mutated human breast cancer cell line.
Kim JY; Kim CH; Stratford IJ; Patterson AV; Hendry JH
Int J Radiat Oncol Biol Phys; 2004 Feb; 58(2):376-85. PubMed ID: 14751506
[TBL] [Abstract][Full Text] [Related]
19. Abrogation of taxol-induced G2-M arrest and apoptosis in human ovarian cancer cells grown as multicellular tumor spheroids.
Frankel A; Buckman R; Kerbel RS
Cancer Res; 1997 Jun; 57(12):2388-93. PubMed ID: 9192815
[TBL] [Abstract][Full Text] [Related]
20. Inactivation of p53 in a human ovarian cancer cell line increases the sensitivity to paclitaxel by inducing G2/M arrest and apoptosis.
Vikhanskaya F; Vignati S; Beccaglia P; Ottoboni C; Russo P; D'Incalci M; Broggini M
Exp Cell Res; 1998 May; 241(1):96-101. PubMed ID: 9633517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
